Immunovant Inc
NASDAQ:IMVT
Cash Flow Statement
Cash Flow Statement
Immunovant Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||
Net Income |
(46)
|
(66)
|
(93)
|
(114)
|
(100)
|
(107)
|
(111)
|
(128)
|
(138)
|
(157)
|
(167)
|
(177)
|
(199)
|
(211)
|
(245)
|
(255)
|
(243)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Stock-Based Compensation |
0
|
7
|
11
|
14
|
20
|
19
|
19
|
24
|
28
|
34
|
38
|
38
|
37
|
32
|
35
|
38
|
0
|
|
Other Non-Cash Items |
6
|
8
|
13
|
17
|
17
|
19
|
20
|
25
|
28
|
35
|
39
|
38
|
38
|
33
|
36
|
39
|
40
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
9
|
5
|
14
|
7
|
(1)
|
5
|
0
|
16
|
14
|
15
|
(23)
|
(12)
|
(5)
|
(11)
|
38
|
7
|
(7)
|
|
Cash from Operating Activities |
(30)
N/A
|
(53)
-76%
|
(67)
-25%
|
(91)
-36%
|
(84)
+8%
|
(83)
+1%
|
(91)
-9%
|
(87)
+5%
|
(96)
-11%
|
(106)
-11%
|
(151)
-42%
|
(151)
0%
|
(165)
-10%
|
(188)
-14%
|
(170)
+10%
|
(210)
-23%
|
(210)
0%
|
|
Investing Cash Flow | ||||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Cash from Investing Activities |
(0)
N/A
|
(0)
-50%
|
115
N/A
|
115
0%
|
(0)
N/A
|
(0)
-62%
|
(0)
+14%
|
(0)
N/A
|
(0)
-28%
|
(0)
-9%
|
(0)
-8%
|
(0)
+4%
|
(0)
-8%
|
(0)
+29%
|
(0)
-5%
|
(0)
N/A
|
(0)
-14%
|
|
Financing Cash Flow | ||||||||||||||||||
Net Issuance of Common Stock |
0
|
0
|
79
|
268
|
386
|
386
|
190
|
1
|
0
|
0
|
0
|
0
|
71
|
71
|
72
|
72
|
477
|
|
Net Issuance of Debt |
38
|
38
|
35
|
35
|
0
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
109
|
109
|
109
|
109
|
(4)
|
(0)
|
0
|
201
|
204
|
200
|
200
|
0
|
(0)
|
(0)
|
0
|
0
|
(6)
|
|
Cash from Financing Activities |
147
N/A
|
147
+0%
|
224
+52%
|
412
+84%
|
382
-7%
|
383
+0%
|
190
-50%
|
201
+6%
|
201
0%
|
200
0%
|
200
0%
|
0
-100%
|
71
+353 150%
|
71
+0%
|
72
+1%
|
72
+0%
|
471
+555%
|
|
Change in Cash | ||||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
1
|
0
|
1
|
2
|
(2)
|
|
Net Change in Cash |
117
N/A
|
94
-20%
|
272
+190%
|
436
+61%
|
298
-32%
|
300
+0%
|
99
-67%
|
115
+16%
|
105
-8%
|
94
-11%
|
48
-49%
|
(153)
N/A
|
(94)
+38%
|
(117)
-24%
|
(97)
+17%
|
(136)
-40%
|
258
N/A
|
|
Free Cash Flow | ||||||||||||||||||
Free Cash Flow |
(30)
N/A
|
(53)
-76%
|
(67)
-26%
|
(91)
-36%
|
(84)
+8%
|
(84)
+1%
|
(91)
-9%
|
(87)
+5%
|
(96)
-11%
|
(106)
-11%
|
(151)
-42%
|
(151)
0%
|
(166)
-10%
|
(188)
-14%
|
(170)
+10%
|
(210)
-23%
|
(211)
0%
|